Sign in

CIK 0001783183

  • Non-accelerated filer
  • Smaller reporting company

Phathom Pharmaceuticals, Inc.

Sign in to watch
Ticker
PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
824151574
Phone
+1 877-742-8466
Business address
100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-19 KARBE FRANK Director Grant or award +24,122 91,622
2025-06-03 KARBE FRANK Director Grant or award +10,500 67,500
2025-06-03 KARBE FRANK Director Grant or award · Stock Option (Right to Buy) +17,500 17,500
2024-12-13 KARBE FRANK Director Purchase +12,500 $7.93 $99K 57,000
2024-05-29 KARBE FRANK Director Grant or award +25,000 $10.16 $254K 44,500
2024-05-23 KARBE FRANK Director Grant or award +10,500 19,500
2024-05-23 KARBE FRANK Director Grant or award · Stock Option (Right to Buy) −17,500 17,500
2023-05-25 KARBE FRANK Director Grant or award +9,000 9,000
2023-05-25 KARBE FRANK Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2022-05-25 KARBE FRANK Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2022-04-25 KARBE FRANK Director Grant or award · Stock Option (Right to Buy) +20,000 20,000

Page 1 of 1 · 11 trades